SMARCA4 deficient non-small cell lung cancer (NSCLC): A comprehensive genomic profiling (CGP) study von Graziano, S.L., Lin, D., Elvin, J.A., Vergilio, J.-A., Killian, J.K., Ngo, N., Ramkissoon, S., Severson, E., Hemmerich, A., Duncan, D., Edgerly, C., Ali, S.M., Schrock, A.B., Chung, J., Sokol, E.S., Reddy, P., McGregor, K., Miller, V.A., Alexander, B.M., Ross, J.S.

Volltext

1583P - SMARCA4 deficient non-small cell lung cancer (NSCLC): A comprehensive genomic profiling (CGP) study von Graziano, S.L., Lin, D., Elvin, J.A., Vergilio, J.-A., Killian, J.K., Ngo, N., Ramkissoon, S., Severson, E., Hemmerich, A., Duncan, D., Edgerly, C., Ali, S.M., Schrock, A.B., Chung, J., Sokol, E.S., Reddy, P., McGregor, K., Miller, V.A., Alexander, B.M., Ross, J.S.

Volltext

A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) von Stinchcombe, T.E., Janne, P.A., Wang, X., Bertino, E.M., Weiss, J.M., Bazhenova, L., Gu, L., Lau, C.J., Paweletz, C.P., Jaslowski, A.J., Gerstner, G.J., Baggstrom, M.Q., Graziano, S.L., Bearden, J., Vokes, E.E.

Volltext

NTRK1-3 genomic fusions in non-small cell lung cancer (NSCLC) determined by comprehensive genomic profiling von Ou, S-H I, Sokol, E.S., Trabucco, S.E., Jin, D.X., Frampton, G.M., Graziano, S.L., Elvin, J.A., Vergilio, J.-A., Killian, J.K., Ngo, N., Lin, D., Ramkissoon, S., Severson, E., Ali, S.M., Schrock, A.B., Chung, J., Reddy, P., McGregor, K., Alexander, B.M., Ross, J.S.

Volltext

1549P - NTRK1-3 genomic fusions in non-small cell lung cancer (NSCLC) determined by comprehensive genomic profiling von Ou, S-H I, Sokol, E.S., Trabucco, S.E., Jin, D.X., Frampton, G.M., Graziano, S.L., Elvin, J.A., Vergilio, J.-A., Killian, J.K., Ngo, N., Lin, D., Ramkissoon, S., Severson, E., Ali, S.M., Schrock, A.B., Chung, J., Reddy, P., McGregor, K., Alexander, B.M., Ross, J.S.

Volltext

Isolation and characterization of microsatellite loci from the Arctic cisco (Coregonus autumnalis) von RAMEY, A, GRAZIANO, S.L, NIELSEN, J.L

Volltext

568 Prognostic significance of K- ras codon 12 mutations and p53 expression in patients with resected stage I and II non-small cell lung cancer (NSCLC) von Graziano, S.L., Poiesz, B.J., Newman, N., Abbott, L., Gamble, G., Rooney, M., Mookherjee, S., Lamb, M., Kohman, L.

Volltext

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720 von Baer, M R, George, S L, Sanford, B L, Mrózek, K, Kolitz, J E, Moore, J O, Stone, R M, Powell, B L, Caligiuri, M A, Bloomfield, C D, Larson, R A

Volltext